Characterization of phenylalanine hydroxylase gene variants and analysis of genotype–phenotype correlation in patients with phenylalanine hydroxylase deficiency from Fujian Province, Southeastern China

[1]  Kong Xiangdong,et al.  Clinical application of non-invasive prenatal diagnosis of phenylketonuria based on haplotypes via paired-end molecular tags and weighting algorithm , 2021, BMC medical genomics.

[2]  H. Pan,et al.  Molecular diagnosis of phenylketonuria in 157 Chinese families and the results of prenatal diagnosis in these families , 2021, Chinese medical journal.

[3]  Yudong Wang,et al.  Phenylalanine hydroxylase deficient phenylketonuria comparative metabolomics identifies energy pathway disruption and oxidative stress. , 2021, Molecular genetics and metabolism.

[4]  H. Shintaku,et al.  Clinical and Genetic Characteristics of Patients with Mild Hyperphenylalaninemia Identified by Newborn Screening Program in Japan , 2021, International journal of neonatal screening.

[5]  G. Leipnitz,et al.  Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation , 2021, Molecular Neurobiology.

[6]  A. Amorim,et al.  Phenylketonuria in Portugal: Genotype–phenotype correlations using molecular, biochemical, and haplotypic analyses , 2021, Molecular genetics & genomic medicine.

[7]  L. Galatz,et al.  Tendinopathy , 2021, Nature Reviews Disease Primers.

[8]  S. Mehrotra,et al.  Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis , 2021, BMC Medical Genomics.

[9]  R. Ligabue-Braun,et al.  Phenylketonuria Diagnosis by Massive Parallel Sequencing and Genotype-Phenotype Association in Brazilian Patients , 2020, Genes.

[10]  Xiulian Liu,et al.  Variants of the phenylalanine hydroxylase gene in neonates with phenylketonuria in Hainan, China , 2020, Scandinavian journal of clinical and laboratory investigation.

[11]  Xiaoze Li,et al.  Spectrum of PAH gene mutations and genotype-phenotype correlation in patients with phenylalanine hydroxylase deficiency from Shanxi province , 2020, Brain and Development.

[12]  Narjes Forouzanfar,et al.  Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[13]  L. Wu,et al.  Noninvasive fetal genotyping in pregnancies at risk for PKU using a comprehensive quantitative cSMART assay for PAH gene mutations: a clinical feasibility study , 2019, BJOG : an international journal of obstetrics and gynaecology.

[14]  P. Guldberg,et al.  Phenylalanine hydroxylase genotype-phenotype associations in the United States: A single center study. , 2019, Molecular genetics and metabolism.

[15]  Xu Ma,et al.  Evaluation of droplet digital PCR for non-invasive prenatal diagnosis of phenylketonuria , 2019, Analytical and Bioanalytical Chemistry.

[16]  X. Mo,et al.  In vitro residual activities in 20 variants of phenylalanine hydroxylase and genotype-phenotype correlation in phenylketonuria patients. , 2019, Gene.

[17]  J. Vockley,et al.  Phenylketonuria: Current Treatments and Future Developments , 2019, Drugs.

[18]  K. Lindorff-Larsen,et al.  Toward mechanistic models for genotype–phenotype correlations in phenylketonuria using protein stability calculations , 2019, Human mutation.

[19]  Xu Ma,et al.  Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants , 2019, Metabolic Brain Disease.

[20]  Q. Shu,et al.  Mutational and phenotypic spectrum of phenylalanine hydroxylase deficiency in Zhejiang Province, China , 2018, Scientific Reports.

[21]  Nenad Blau,et al.  Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria. , 2018, Molecular genetics and metabolism.

[22]  Hui Jiang,et al.  Analysis of the genotype-phenotype correlation in patients with phenylketonuria in mainland China , 2018, Scientific Reports.

[23]  N. Blau,et al.  Allelic phenotype values: a model for genotype-based phenotype prediction in phenylketonuria , 2018, Genetics in Medicine.

[24]  N. Blau,et al.  Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[25]  Huan Yan,et al.  Mutational spectrum of the phenylalanine hydroxylase gene in patients with phenylketonuria in the central region of China , 2018, Scandinavian journal of clinical and laboratory investigation.

[26]  D. Cram,et al.  Non-invasive prenatal testing of pregnancies at risk for phenylketonuria , 2018, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[27]  S. Chandna,et al.  Evidence for a radiation-responsive ‘p53 gateway’ contributing significantly to the radioresistance of lepidopteran insect cells , 2018, Scientific Reports.

[28]  Dong Hwan Lee,et al.  Reassessing the significance of the PAH c.158G>A (p.Arg53His) variant in patients with hyperphenylalaninemia , 2017, Journal of pediatric endocrinology & metabolism : JPEM.

[29]  X. Kong,et al.  Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China , 2017, BMC Medical Genetics.

[30]  Jun Zhu,et al.  Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing , 2015, Scientific Reports.

[31]  Xuefan Gu,et al.  Variations in genotype-phenotype correlations in phenylalanine hydroxylase deficiency in Chinese Han population. , 2013, Gene.

[32]  T. Flatmark,et al.  Heterotetrameric forms of human phenylalanine hydroxylase: co-expression of wild-type and mutant forms in a bicistronic system. , 2011, Biochimica et biophysica acta.

[33]  S. Kudo,et al.  Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan , 2011, Journal of Human Genetics.

[34]  Shengying Qin,et al.  Mutational Spectrum of Phenylketonuria in the Chinese Han Population: A Novel Insight into the Geographic Distribution of the Common Mutations , 2010, Pediatric Research.

[35]  Dong Hwan Lee,et al.  Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria , 2008, Experimental & Molecular Medicine.

[36]  L. Serrano,et al.  Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. , 2007, American journal of human genetics.

[37]  M. Asada,et al.  Molecular characterization of phenylketonuria in Japanese patients , 1998, Human Genetics.

[38]  [Consensus statement on dietary treatment and nutritional management for phenylalanine hydroxylase deficiency]. , 2019, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[39]  Wei-peng Wang,et al.  Newborn screening for inborn errors of metabolism in mainland china: 30 years of experience. , 2012, JIMD reports.